Wikipedia

Mary C. Tanner

Mary Catherine Tanner is an investment banker, with more than 25 years of experience on Wall Street. She specializes in the areas of biotechnology, pharmaceuticals, and health care services.[4][5] Her expertise includes ethical pharmaceuticals and green technology.[1] Fluent in both English and French, she specializes in cross-border transactions between large and small companies, corporate partnering and minority investments.[4][5]

Mary C. Tanner
Born(1951-10-10)10 October 1951
Alma materHarvard University
SpouseFrederick Frank[1][2][3]
Scientific career
FieldsInvestment banking, biotechnology
InstitutionsEVOLUTION Life Science Partners, Peter J. Solomon Company, Lehman Brothers

As of 2014, Tanner was Senior Managing Director of EVOLUTION Life Science Partners (ELSP), and a co-founder and chair of Life Science Partners LLP. Previously she served as Senior Managing Director of Lehman Brothers, Bear Stearns, and the Peter J. Solomon Company.[4][5] Tanner was the first woman to become a partner at Lehman Brothers.[6] She is credited with directing over 130 IPOs for life sciences organizations,[5] and over 500 mergers and acquisitions.[4]

Early life and education edit

Mary Catherine Tanner was born to Donald N. Tanner and Marilyn S. Tanner. Her father was a civil engineer. Her mother was an educator working with learning-disabled children.[3] Tanner graduated from Harvard University in 1973 with a B.A. in philosophy,[6][5] magna cum laude.[1]

Career edit

In 1978, Tanner was included in a team at Lehman Brothers, to handle Humana's acquisition of American Medicorp. The team was led by Frederick Frank.[7] Frank convinced Tanner to join his team at Lehman. Ten years later, on October 15, 1988, they were married.[3] Tanner became Senior Managing Director of Lehman Brothers,[1] while Frank became vice chair of Lehman Brothers. Frank and Tanner worked together at Lehman for over ten years, until Tanner took time off to have a child.[2]

Tanner returned to work as the Senior Managing Director at Bear Stearns as of 2000,[2] and retired from Bear Stearns in 2004, to found Life Sciences Partners.[8]

As of March 18, 2009, Mary Tanner and Frederick Frank joined Peter J. Solomon, of PJ SOLOMON to form a new practice focusing on pharmaceuticals and life sciences.[9] Tanner became a managing director at Peter J. Solomon, while Frank became a vice chairman.[10]

As of January 15, 2013, Mary Tanner and Frederick Frank joined Burrill & Company.[11] Tanner became the Senior Managing Director of Burrill Securities and of Burrill & Company.[11][6]

As of 2014, Tanner and Frank founded EVOLUTION Life Science Partners (ELSP).[12] Tanner is Senior Managing Director of EVOLUTION Life Science Partners (ELSP), and a co-founder and chair of Life Science Partners LLP.[4]

Tanner has served on numerous advisory groups and boards of directors.[6] She is credited with over 130 IPOs[5] and over 500 mergers and acquisitions for life sciences organizations.[4] During her time at Lehmann, Tanner represented Rhône-Poulenc when it acquired Rorer for $1.8 billion in 1990, and in 1995 represented Rhône-Poulenc Rorer when it acquired Fisons for £1.8 billion.[5][11] Together, Tanner and Frederick Frank represented Marion Merrell Dow in its merger with Hoechst AG, forming Hoechst Marion Roussel, Inc. in 1995.[11] While at Bear Stearns, Tanner represented Pfizer when it acquired Pharmacia for $60 billion (2002-2003).[9][13] She also represented Amgen when it acquired Immunex for $16 billion.[5][11]

Philanthropy edit

As of October, 1997, the non-profit Tanner Frank Foundation of New York City was granted charitable status.[14] Tanner has served on the Dean's Council for the Yale School of Medicine and on the advisory board for the Yale School of Management (SOM).[5] Tanner and Frank have made multiple gifts to Yale,[14] including early career support of researchers in autism at the Yale School of Medicine,[15] and the creation of the Frank and Tanner Professor of Management at the Yale School of Management, to which Olav Sorenson was appointed on April 9, 2012.[16]

Awards and honors edit

  • 2012, Oracle award, Springboard Enterprises,[17][18] for professional accomplishment and mentoring of women entrepreneurs.[1]

References edit

  1. ^ a b c d e "Advisory Council : Mary Tanner". LifeSciNYC. Retrieved 14 May 2019.
  2. ^ a b c Abkowitz, Alyssa (March 20, 2009). "Health care's dealmaking couple is back Frank and Tanner, the first family of pharma finance, are together again in time for the industry's wave of consolidation". Fortune. Retrieved 14 May 2019.
  3. ^ a b c "Mary C. Tanner Becomes a Bride". The New York Times. October 16, 1988. Retrieved 14 May 2019.
  4. ^ a b c d e f "Presented by Yale Office of Cooperative Researchand Yale Entrepreneurial Institute Connecting Innovators and Investors at Yale" (PDF). Yale Innovation Summit. 2017. Retrieved 17 May 2019.
  5. ^ a b c d e f g h i Tidmarsh, Mark (September 19, 2014). "Mary Tanner Appointed To Genticel's Supervisory Board As Independently-Acting Member". Biospace. Retrieved 16 May 2019.
  6. ^ a b c d "Mary C. Tanner". Bloomberg. Retrieved 14 May 2019.
  7. ^ "The Ubiquitous Frederick Frank" (PDF). TechHistoryWorks. Retrieved 15 May 2019.
  8. ^ "21st CENTURY PHARMA IMS Pharma Strategy Series Webinar" (PDF). In VIVO; the business and medicine report. June 12, 2008. Retrieved 17 May 2019.
  9. ^ a b Cohan, William D. (March 27, 2009). "Dream-team investment banking As old Wall Street crumbles, industry veteran Peter J. Solomon snaps up a few of its superstars". CNN. Retrieved 14 May 2019.
  10. ^ Dealbook (March 19, 2009). "Veteran Bankers in Health Care Join Peter J. Solomon". The New York Times. Retrieved 16 May 2019.
  11. ^ a b c d e "Storied Life Sciences Investment Bankers Frederick Frank and Mary Tanner Join Burrill & Company". Marketwire. January 7, 2013. Retrieved 14 May 2019.
  12. ^ "Marsala Biotech Engages Evolution Life Science Partners to Provide Financial and Strategic Advisory Services". Marsala Biotech. October 3, 2016. Retrieved 20 May 2019.
  13. ^ "It's official: Pfizer buys Pharmacia". CNN Money. April 16, 2003. Retrieved 17 May 2019.
  14. ^ a b "TANNER FRANK FOUNDATION". BIG Online: US Foundation Summary. Retrieved 16 May 2019.
  15. ^ Horsting, Rachel (September 14, 2017). "Awards to support early career researchers in autism". Yale School of Medicine. Retrieved 17 May 2019.
  16. ^ "Sorenson is appointed the first Frank and Tanner Professor of Management". Yale News. April 9, 2012. Retrieved 14 May 2019.
  17. ^ Koplovitz, Kay (October 30, 2012). "Women Powering the Global Economy By Daring to Be Great". HuffPost. Retrieved 17 May 2019.
  18. ^ "Enterprising Women". Enterprising Women Magazine. 13 (3): 14. 2012. Retrieved 17 May 2019.
Retrieved from "https://en.wikipedia.org/w/index.php?title=Mary_C._Tanner&oldid=1215745260"